LivaNova – BIBA Medtech Insights

LivaNova bow out of transcatheter mitral valve replacement

A press release reports that LivaNova is to discontinue its Caisson transcatheter mitral valve replacement programme and will undertake a restructuring of its heart valve business to improve profitability and ensure business continuity. It adds that LivaNova’s heart valve business line represented nearly $130 million in revenue for full-year 2018 and has experienced a [...]

LivaNova launches its Bi-flow arterial femoral cannula

Bi-Flow LivaNova has launched its arterial femoral cannula, Bi-Flow, onto the market. The catheter, which received the CE mark earlier this year, is designed to prevent limb ischaemia during cardiac surgery that requires femoral artery cannulation. In a clinical study, a press release states, Bi-Flow was easily inserted and removed without complications [...]